ŌURA, the Finnish company known for its smart ring providing personalized health data, insights, and guidance, announced today the formation of a Medical Advisory Board. The board is designed to reinforce ŌURA’s commitment to advancing the science and technology behind the Oura Ring, which has evolved from a sleep tracking device to encompass holistic health data on aspects such as reproductive health, cardiovascular health, and physical activity.
The Medical Advisory Board consists of Dr. Kiarra King, Dr. Rebecca Robbins, Dr. Christine Noa Sterling, and Dr. Matthew Walker, with more members expected to join in the coming months. These experts bring diverse perspectives on various health-related topics, including fertility, pregnancy, menopause, and sleep. They will collaborate on research, feature development, and educational content for the ŌURA community.
ŌURA has seen significant growth in the last decade, with recent milestones including selling its millionth Oura Ring, a valuation of $2.55 billion, and a major retail partnership with Best Buy. The company has also released the Oura Horizon, a sleek design featuring Gen3 technology, and partnered with Natural Cycles, the first FDA-cleared birth control app, to enhance reproductive health offerings.
In addition to being recognized with numerous awards, ŌURA is investing heavily in research and development in areas such as women’s health, illness detection, sleep, stress, and mental health. By collaborating with research institutions like the University of California San Diego and the University of California San Francisco, ŌURA aims to contribute to the growing body of knowledge on COVID-19, reproductive health, and the future of public health.
